The Centers for Disease Control and Prevention is working with the U.S. Embassy in the Democratic Republic of the Congo to preposition staff in Goma to rapidly identify Ebola cases and prevent further spread of the disease in hotspots where the security situation permits, the agency said last night. The World Health Organization yesterday declared the Ebola outbreak in DRC a public health emergency of international concern, citing in part the first confirmed case in Goma, a city of almost 2 million people on the border with Rwanda. CDC said it has 43 permanent staff in DRC and about 200 in the bordering countries of Rwanda, Uganda and South Sudan. The agency activated its Emergency Operations Center in June to support the interagency response to the outbreak following confirmation of three travel-associated cases in Uganda. “Make no mistake, the challenges to stopping the Ebola outbreak are growing steeper and the public health response will unquestionably be longer,” said CDC Director Robert Redfield, M.D. The agency said the U.S. risk from the DRC outbreak remains low based on travel volume and patterns from the outbreak area. For more information on Ebola, visit https://www.cdc.gov/vhf/ebola.
 

Related News Articles

Headline
The Food and Drug Administration yesterday approved the first FDA-approved vaccine to prevent Ebola in adults with Zaire ebolavirus, which killed more…
Headline
The Food and Drug Administration last week authorized marketing of a rapid diagnostic test to detect Ebola virus antigens in human blood from certain living…
Headline
The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which…
Headline
The World Health Organization recently deployed a rapid response team and personal protective equipment to the United Republic of Tanzania following unofficial…
Headline
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will provide $23 million for Merck to produce…
Headline
Patients receiving either of two investigational treatments for Ebola in the Democratic Republic of the Congo had a greater chance of survival than those…